World Health Organization. (2022). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO.
[2]
European Association of Urology. (2023). Guidelines on Renal Cell Carcinoma.
[3]
American Urological Association. (2022). Guidelines for the Management of Renal Masses.
[4]
Moch H, et al. (2022). The 2022 WHO Classification of Tumours of the Urinary System and Male Genital Organs. European Urology, 82(5), 458-468.
[5]
Hes O. (2021). Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Pathology Research International, 2021, 1-12.
[6]
Jinzaki M, et al. (2020). Angiomyolipoma: Imaging Findings in Benign Renal Tumors. Radiology, 295(3), 456-468.
[7]
National Comprehensive Cancer Network. (2023). NCCN Guidelines: Kidney Cancer Version 3.2023.
[8]
Bhatt JR, et al. (2019). Natural History of Renal Angiomyolipoma. Journal of Urology, 202(4), 725-731.